Literature DB >> 11405332

Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States).

H F Tsen1, H Morgenstern, T Mack, R K Peters.   

Abstract

UNLABELLED: The etiology of penile cancer is poorly understood, with neonatal circumcision being one of the few recognized nondemographic risk factors. Multiple logistic regression was used to analyze interview data from 100 matched case-control pairs; cases of carcinoma in situ (CIS) and invasive carcinoma of the penis were analyzed separately as well as together. Phimosis was strongly associated with invasive carcinoma (adjusted odds ratio [OR] = 16; 95% confidence interval [CI] = 4.5-57) but not CIS (OR = 1.7; 95% CI = 0.32-7.8), and these associations persisted when the analyses were restricted to uncircumcised subjects. Neonatal circumcision was inversely associated with invasive carcinoma (OR = 0.41; 95% CI = 0.13-1.1) but not CIS, and the observed association with invasive carcinoma was weakened appreciably when the analysis was restricted to subjects with no history of phimosis (OR = 0.79; 95% CI = 0.29-2.6). Other factors positively associated with invasive carcinoma or CIS or both were injury to the penis, cigarette smoking, physical inactivity and, to a lesser extent, genital warts and other infections or inflammation of the penis.
CONCLUSIONS: Although many effects were imprecisely estimated in this study, the protective effect of circumcision on invasive penile cancer appears to be mediated in large part by phimosis; furthermore, the effects of certain factors such as phimosis and circumcision appear to differ for CIS and invasive carcinoma.

Entities:  

Mesh:

Year:  2001        PMID: 11405332     DOI: 10.1023/a:1011266405062

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  50 in total

1.  Does sexual function survey in Denmark offer any support for male circumcision having an adverse effect?

Authors:  Brian J Morris; Jake H Waskett; Ronald H Gray
Journal:  Int J Epidemiol       Date:  2011-11-28       Impact factor: 7.196

2.  Newborn male circumcision.

Authors:  S Todd Sorokan; Jane C Finlay; Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

Review 3.  Parachute approach to evidence based medicine.

Authors:  Malcolm Potts; Ndola Prata; Julia Walsh; Amy Grossman
Journal:  BMJ       Date:  2006-09-30

4.  Is neonatal circumcision clinically beneficial? Argument in favor.

Authors:  Paul F Austin
Journal:  Nat Clin Pract Urol       Date:  2008-12-09

Review 5.  Is neonatal circumcision clinically beneficial? Argument against.

Authors:  Robert S Van Howe
Journal:  Nat Clin Pract Urol       Date:  2009-01-20

Review 6.  Advanced penile cancer.

Authors:  Jonathan E Heinlen; David D Buethe; Daniel Joseph Culkin
Journal:  Int Urol Nephrol       Date:  2011-08-04       Impact factor: 2.370

7.  Reduced clearance of penile human papillomavirus infection in uncircumcised men.

Authors:  Brenda Y Hernandez; Yurii B Shvetsov; Marc T Goodman; Lynne R Wilkens; Pamela Thompson; Xuemei Zhu; Lily Ning
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

8.  Buried penis: An unrecognized risk factor in the development of invasive penile cancer.

Authors:  Alym Abdulla; Dean Daya; Jehonathan Pinthus; Timothy Davies
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

9.  Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003.

Authors:  Brenda Y Hernandez; Jill Barnholtz-Sloan; Robert R German; Anna Giuliano; Marc T Goodman; Jessica B King; Serban Negoita; Jose M Villalon-Gomez
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

10.  Circumcision and human papillomavirus infection in men: a site-specific comparison.

Authors:  B Y Hernandez; L R Wilkens; X Zhu; K McDuffie; P Thompson; Y B Shvetsov; L Ning; M T Goodman
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.